(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEUMORA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NEUMORA

ST13

US500000090574634

Class

42

Filing

90574634

Registration

7429686

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

07/16/2026

Trademark type

Combined

Nice classes

42

Filing date

03/11/2021

Registration date

06/25/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/25/2024

Last transaction

07/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2023-09-00

First use in commerce

2023-09-00

Drawing code

3

Owner type

03

Owner location

Watertown, MA, US

Examiner

GULIANO, ROBERT N

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a brain tree design and the word "NEUMORA".

Holders and representatives

Holders

NEUMORA THERAPEUTICS, INC
RBNC Therapeutics, Inc.

Representatives

Lisa Greenwald-Swire Fish & Richardson P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of pharmaceutical preparations and substances for the treatmentmanagement and prevention of neurological diseases and disorderspsychiatric diseases and disorderscentral nervous system conditionsbrain disorders and sleep disorders; Analyzing geneticgenomicbiological and clinical data for scientific research purposes; Analyzing geneticgenomicbiological and clinical data for the research and development pharmaceuticals for treating neurological diseases and disorderspsychiatric diseases and disorderscentral nervous system conditionsbrain disorders and sleep disorders via targeted drug therapies

Publications

History of USPTO decisions and trademark events.

49 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/25/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/25/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/20/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/20/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/19/2024

IUAF

USE AMENDMENT FILED

04/17/2024

EISU

TEAS STATEMENT OF USE RECEIVED

04/17/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/12/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/12/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/12/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/04/2023

EX3G

SOU EXTENSION 3 GRANTED

11/02/2023

EXT3

SOU EXTENSION 3 FILED

11/02/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/02/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/08/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/08/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/08/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/08/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/08/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/02/2023

EX2G

SOU EXTENSION 2 GRANTED

04/28/2023

EXT2

SOU EXTENSION 2 FILED

04/28/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/28/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/27/2022

EX1G

SOU EXTENSION 1 GRANTED

10/25/2022

EXT1

SOU EXTENSION 1 FILED

10/25/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/25/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/09/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/22/2022

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

05/18/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/10/2022

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

03/27/2022

CHPB

POST PUBLICATION AMENDMENT - ENTERED

01/26/2022

APET

ASSIGNED TO PETITION STAFF

01/24/2022

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

01/07/2022

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

12/14/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/16/2021

PUBO

PUBLISHED FOR OPPOSITION

11/16/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/03/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/27/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/08/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

10/08/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/08/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

10/08/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/08/2021

DOCK

ASSIGNED TO EXAMINER

10/06/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/15/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/12/2021

NWAP

NEW APPLICATION ENTERED

03/15/2021

Continuous trademark protection

Get notified about every new filing that threatens NEUMORA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.